GSK3B and glioma: In our study, Phosphodiesterase 2A (PDE2A) was up-regulated, a gene known to suppress Wnt/β-catenin signaling in glioma stem-like cells by modulating cAMP accumulation and GSK-3β phosphorylation [55].